Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: A clinical case series

Behaviour Research and Therapy

Volumn 37, Issue 8, 1999, Pages 763-770

  Otto, Michael W ^a   Pollack, Mark H ^a   Penava, Susan J ^a   Zucker, Bonnie G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Behavior therapy; Cognitive behavior therapy; Nonresponders; Panic disorder; Pharmacotherapy; Treatment resistance

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROUP THERAPY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PANIC;

ADULT; AGORAPHOBIA; AMBULATORY CARE; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; COGNITIVE THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHOTHERAPY, GROUP; TREATMENT FAILURE;

EID: 0033057760     PISSN: 00057967     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-7967(98)00176-4     Document Type: Article

References (27)

1. Barlow D.H. Health care policy, psychotherapy research and the future of psychotherapy. American Psychologist. 51:1996;1050-1058.
2. Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (1997). Results from the multicenter comparative treatment study of panic disorder: acute and maintenance outcome. Paper presented at the British Association of Behavioural and Cognitive Psychotherapy, Canterbury, UK, July.
3. Clark D.M., Salkovskis P.M., Hackmann A., Middleton H., Pavlos A., Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry. 164:1994;759-769.
4. Clum G.A., Clum G.A., Surls R. A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology. 61:1993;317-326.
5. Coplan J.D., Pine D.S., Papp L.A., Gorman J.M. An algorithm-oriented treatment approach for panic disorder. Psychiatric Annals. 26:1996;192-201.
6. Cowley, D. S., Ha, E. H., & Roy-Byrne, P. P. Eds (1997). Determinants of pharmacologic treatment failure in panic disorder. Journal of Clinical Psychiatry, 58, 555.
7. Fava G.A., Savron G., Zielezny M., Grandi S., Rafanelli C., Conti S. Overcoming resistance to exposure in panic disorder with agoraphobia. Acta Psychiatrica Scandinavica. 95:1997;306-312.
8. Gould R.A., Otto M.W., Pollack M.H. A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review. 15:1995;819-844.
9. Guy, W. (1976). Assessment manual for psychopharmacology. Washington, DC: US Government Printing Office.
10. Hoffart A., Due-Madsen J., Lande B., Gude T., Bille H., Torgersen S. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy. Journal of Clinical Psychiatry. 54:1993;481-487.
11. Klosko J.S., Barlow D.H., Tassinari R.B., Cerny J.A. Comparison of alprazolam and behavior therapy in the treatment of panic disorder. Journal of Consulting and Clinical Psychology. 58:1990;77-84.
12. Marks I.M., Swinson R.P., Basoglu M., Kuch K., Noshirvani H., O'Sullivan G., Lelliott P.T., Kirby M., McNamee G., Sengun S., Wickwire K. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. British Journal of Psychiatry. 162:1993;776-787.
13. Otto, M. W., & Gould, R. A. (1996). Maximizing treatment-outcome for panic disorder: cognitive-behavioral strategies. In M. H. Pollack, M. W. Otto, & J. F. Rosenbaum (Eds.), Challenges in clinical practice: pharmacologic and psychosocial strategies (pp. 113-140). New York: Guilford Press.
14. Otto M.W., Gould R.A., McLean R.Y.S. The effectiveness of cognitive-behavior therapy for panic disorder without concurrent medication treatment: a reply to Power and Sharp (letter). Journal of Psychopharmacology. 10:1996;254-256.
15. Otto, M. W., Jones, J. C., Craske, M. G., & Barlow, D.H. (1996b). Stopping anxiety medication: panic control therapy for benzodiazepine discontinuation (therapist guide). New York: Psychological Corporation.
16. Otto, M. W., Pollack, M. H., Maki, K. M., & Penava, S. J. (1997). The costs and benefits of cognitive-behavioral and pharmacologic treatments for panic disorder. Paper presented at the European Association for Behavioural & Cognitive Therapies congress in Venice, Italy, September 24-27.
17. Otto M.W., Pollack M.H., Sabatino S.A. Maintenance of remission following cognitive-behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment. Behavior Therapy. 27:1996;473-482.
18. Otto M.W., Whittal M.L. Cognitive-behavior therapy and the longitudinal course of panic disorder. Psychiatric Clinics of North America. 18(4):1995;803-820.
19. Penava S.J., Otto M.W., Maki K.M., Pollack M.H. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behaviour Research and Therapy. 36:1998;665-673.
20. Pollack, M. H., & Smoller, J. W. (1996). Pharmacologic approaches to treatment-resistant panic disorder. In M. H. Pollack, M. W. Otto, & J. F. Rosenbaum (Eds.) Challenges in clinical practice: pharmacologic and psychosocial strategies (pp. 89-112). New York: Guilford Press.
21. Pollack M.H., Otto M.W., Kaspi S.P., Hammerness P.G., Rosenbaum J.F. Cognitive-behavior therapy for treatment-refractory panic disorder. Journal of Clinical Psychiatry. 55:1994;200-205.
22. Roy-Byrne P.P., Cowley D.S. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety. 1:1995;151-160.
23. Sharp D.M., Power K.G., Simpson R.J., Swanson V., Moodie E., Anstee J.A., Ashford J.J. Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. Journal of Anxiety Disorders. 10:1996;219-242.
24. Shear M.K., Brown T.A., Barlow D.H., Money R., Sholomskas D.E., Woods S.W., Gorman J.M., Papp L.A. Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry. 154:1997;1571-1575.
25. Telch, M. J., & Lucas, R. A. (1994). Combined pharmacological and psychological treatment of panic disorder: current status and future directions. In B. E. Wolfe, & J. D. Maser (Eds.), Treatment of Panic Disorder. Washington DC: American Psychiatric Press.
26. Telch M.J., Agras W.S., Taylor C.B., Roth W.T., Gallen C. Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy. 23:1985;325-335.
27. Telch M.J., Lucas J.A., Schmidt N.B., Hanna H.H., Jaimez T.L., Lucas R.A. Group cognitive-behavioral treatment of panic disorder. Behaviour Research and Therapy. 31:1993;279-287.